Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells.

[1]  Xiao-fei Zhang,et al.  Protective effects of ion-imprinted chitooligosaccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells. , 2011, Toxicology.

[2]  Gang Liu,et al.  1-(2-Hydroxyethoxy)Methyl-2-Methyl-3-Hydroxyl-4-Pyridinone: ATargeted, Bifunctional Chelating Agent for Potential Uranic Detoxification in the Kidney , 2011, Hemoglobin.

[3]  Deborah I. Bunin,et al.  Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO). , 2010, Health physics.

[4]  J. Zielinski,et al.  Uranium in Drinking Water: Renal Effects of Long-Term Ingestion by an Aboriginal Community , 2009, Archives of environmental & occupational health.

[5]  Yuyuan Xie,et al.  ACUTE TOXICITY OF SUBCUTANEOUSLY ADMINISTERED DEPLETED URANIUM AND THE EFFECTS OF CBMIDA IN THE SIMULATED WOUNDS OF RATS , 2009, Health physics.

[6]  R. Bergeron,et al.  Desferrithiocin analogue uranium decorporation agents , 2009, International journal of radiation biology.

[7]  Li Zhi-ming.  Hereditary Toxicity of Depleted Uranium and Protection of DMSO in BEAS-2B Cells , 2009 .

[8]  Y. Xie,et al.  Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium. , 2009, Radiation protection dosimetry.

[9]  Yuyuan Xie,et al.  EFFECTS OF pH ON DU INTAKE AND REMOVAL BY CBMIDA AND EHBP , 2007, Health physics.

[10]  Şermin,et al.  CHEMICAL TOXICITY OF URANIUM , 2007 .

[11]  M. Sun,et al.  Decorporating efficacy of catecholaminocarboxylate chelating agents for thorium-234 and protective effects on associated radiation injury , 2005, International journal of radiation biology.

[12]  J. Harrison,et al.  Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239 and amercium-241. , 2001, International journal of radiation biology.

[13]  Jide Xu,et al.  CHELATING AGENTS FOR URANIUM(VI): 2. EFFICACY AND TOXICITY OF TETRADENTATE CATECHOLATE AND HYDROXYPYRIDINONATE LIGANDS IN MICE , 2000, Health physics.

[14]  Chen Honghon.  STUDIES OF PHENOLIC CHELATING AGENTS ON FREE RADICAL SCAVENGING ACTIVITIES AND INHIBITORY ACTION IN RADIATION-INDUCED LIPID PEROXICATION , 1999 .

[15]  Ni Zhenli.  Structure activity relationship study of chelating agents of double molecular substituted phenols amino carboxylic acid for decorporated radiothorium , 1999 .

[16]  Jide Xu,et al.  New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands. , 1997, Health physics.

[17]  J. Domingo,et al.  Comparative effects of the chelators sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) and diethylenetriaminepentaacetic acid (DTPA) on acute uranium nephrotoxicity in rats. , 1997, Toxicology.

[18]  B. Kullgren,et al.  Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones , 1996, Human & experimental toxicology.

[19]  S. E. Dietert,et al.  A histological kidney study of uranium and non-uranium workers. , 1996, Health physics.

[20]  H. Métivier,et al.  Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration. , 1995, International journal of radiation biology.

[21]  P. Durbin,et al.  Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation. , 1995, Journal of medicinal chemistry.

[22]  M. Ellender,et al.  The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophore analogues. , 1992, International journal of radiation biology.

[23]  M. Bhattacharyya,et al.  Guidebook for the treatment of accidental internal radionuclide contamination of workers , 1992 .

[24]  P. Morrow,et al.  Reversible uranyl fluoride nephrotoxicity in the Long Evans rat. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[25]  P. Durbin,et al.  Chelation of 238Pu(IV) in vivo by 3,4,3-LICAM(C): effects of ligand methylation and pH. , 1989, Health physics.

[26]  J. Domingo,et al.  Acute toxicity of uranium in rats and mice , 1987, Bulletin of environmental contamination and toxicology.

[27]  X. H. Xu,et al.  [Detoxication and mobilization of uranium by catecholamic acid]. , 1987, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[28]  C. Viau,et al.  Kidney disorders and hematotoxicity from organic solvent exposure. , 1985, Scandinavian journal of work, environment & health.

[29]  R. Blantz.  The mechanism of acute renal failure after uranyl nitrate. , 1975, The Journal of clinical investigation.